Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Aristo Bio-Tech IPO is a fixed price issue of ₹13.05 crores. The issue is entirely a fresh issue of 0.18 crore shares of ₹13.05 crore.
Aristo Bio-Tech IPO bidding started from Jan 16, 2023 and ended on Jan 19, 2023. The allotment for Aristo Bio-Tech IPO was finalized on Jan 24, 2023. The shares got listed on NSE SME on Jan 30, 2023.
Aristo Bio-Tech IPO price is ₹72.00 per share . The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹1,15,200 (1600 shares). The minimum lot size investment for HNI is 2 lots (3,200 shares), amounting to ₹2,30,400.
Beeline Capital Advisors Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The market maker of the company is Sunflower Broking Pvt.Ltd..
Refer to Aristo Bio-Tech IPO RHP for detailed Information.
| IPO Date | January 16, 2023 to January 19, 2023 |
| Listing Date | January 30, 2023 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹72 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 18,12,800 shares (aggregating up to ₹13.05 Cr) |
| Reserved for Market Maker | 91,200 shares Sunflower Broking Pvt.Ltd. (aggregating up to ₹0.6566 Cr) |
| Net Offered to Public | 17,21,600 shares (aggregating up to ₹12.40 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 49,95,000 shares |
| Share Holding Post Issue | 68,07,800 shares |
Aristo Bio-Tech and Lifescience IPO offers total 18,12,800 shares. Out of which 8,60,800 (47.48%) allocated to NII, 8,60,800 (47.48%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 91,200 (5.03%) |
| NII (HNI) Shares Offered | 8,60,800 (47.48%) |
| Retail Shares Offered | 8,60,800 (47.48%) |
| Total Shares Offered | 18,12,800 (100.00%) |
Aristo Bio-Tech IPO opens on January 16, 2023, and closes on January 19, 2023.
| IPO Open Date | Mon, Jan 16, 2023 |
| IPO Close Date | Thu, Jan 19, 2023 |
| Tentative Allotment | Tue, Jan 24, 2023 |
| Initiation of Refunds | Wed, Jan 25, 2023 |
| Credit of Shares to Demat | Fri, Jan 27, 2023 |
| Tentative Listing Date | Mon, Jan 30, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Thu, Jan 19, 2023 |
Investors can bid for a minimum of 1,600 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,15,200 |
| Retail (Max) | 1 | 1,600 | ₹1,15,200 |
| HNI (Min) | 2 | 3,200 | ₹2,30,400 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
They deliver their products in India as well as engage in exporting products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators, and a wide variety of other Agrochemicals.
The industry Aristo Bio-Tech and Lifescience is engaged in, is full of possibilities where the entities deal in the production and distribution of pesticides and fertilizers. All these entities contribute towards enhancing crop yields and their quality.
Aristo Bio-Tech and Lifescience are delivering their products in over 20 states of India. Also, the offerings are extended to over 15 countries, including Armenia, Australia, Bangladesh, Belgium, Cambodia, Germany, Italy, Kenya, Moldova, New Zealand, Poland, South Africa, UAE, Ukraine, and Vietnam.
The company is ISO 9001: 2015 certified for their Quality Management System. Following are the products of Aristo:
Alongside undertaking manufacturing operations, the company also provide Contract manufacturing, Job work and Toll manufacturing services for Crop Protection companies.
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Mar-20 | 8,785.12 | 20,123.94 | 100.74 | 1,230.51 | 731.01 | 1,970.97 |
| 31-Mar-21 | 8,141.73 | 16,722.96 | 107.57 | 1,338.08 | 838.58 | 2,224.77 |
| 31-Mar-22 | 7,700.16 | 16,603.29 | 146.17 | 1,484.25 | 984.75 | 2,548.43 |
| 30-Sep-22 | 10,869.14 | 12,907.49 | 258.90 | 1,743.15 | 1,243.65 | 2,935.53 |
| Amount in ₹ Lakhs | ||||||
The market capitalization of Aristo Bio-Tech IPO is ₹49.02 Cr.
| Pre IPO | Post IPO | |
|---|---|---|
| P/E (x) | 9.46 |
The Net Proceeds from the Fresh Issue will be utilized towards the following objects:
[Dilip Davda] Based on its super earnings for H1 of FY23, the IPO is fully priced discounting all near-term positives. The sustainability of such margins going forward is a major concern. The segment too is becoming crowded and highly competitive. Post-IPO small paid-up equity also indicates longer gestation for migration to the main board. Well-informed investors may park funds with a long-term perspective. Read detail review...
| Listing Date | January 30, 2023 |
| BSE Script Code | |
| NSE Symbol | ARISTO |
| ISIN | INE082101010 |
| Final Issue Price | ₹72 per share |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹72.00 |
| Open | ₹80.00 |
| Low | ₹76.05 |
| High | ₹84.00 |
| Last Trade | ₹84.00 |
Aristo Bio-Tech & Lifescience Ltd.
E-24,25,26,
G.I.D.C. Manjusar,
Ta. Savli,
Vadodara, Gujarat, 391775
Phone: +91-2667-264843
Email: cs@aristobiotech.com
Website: http://www.aristobiotech.com/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: aristobio.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Aristo Bio-Tech IPO is a SME IPO of 18,12,800 equity shares of the face value of ₹10 aggregating up to ₹13.05 Crores. The issue is priced at ₹72 per share. The minimum order quantity is 1600.
The IPO opens on January 16, 2023, and closes on January 19, 2023.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Aristo Bio-Tech IPO using UPI as a payment gateway. Zerodha customers can apply in Aristo Bio-Tech IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Aristo Bio-Tech IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Aristo Bio-Tech IPO opens on January 16, 2023 and closes on January 19, 2023.
Aristo Bio-Tech IPO lot size is 1600, and the minimum amount required for application is ₹1,15,200.
You can apply in Aristo Bio-Tech IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Aristo Bio-Tech IPO will be done on Tuesday, January 24, 2023, and the allotted shares will be credited to your demat account by Friday, January 27, 2023. Check the Aristo Bio-Tech IPO allotment status.
The Aristo Bio-Tech IPO listing date is on Monday, January 30, 2023.
Useful Articles
RHP